Controversies in Internal Medicine |

Rebuttal by Mandelblatt, Lawrence, Yi, and King

Jeanne Mandelblatt, MD,MPH; William Lawrence, MD,MSc; Bin Yi, MS; Jason King, MPH
Arch Intern Med. 2004;164(3):248. doi:10.1001/archinte.164.3.248.
Text Size: A A A
Published online


No clinician would argue that the first consideration in deciding to offer a preventive service is that we do no harm. This credo would be easier to adhere to if all physicians had a crystal ball in their armamentarium. In addition to projecting future risk of cervical cancer, we need to know whether a woman is destined to die of another cause before she would develop cervical cancer. Older women are a remarkably heterogeneous group and many have very long life expectancies. At present, the rates of cervical cancer in previously screened women are low. However, there are several reasons to believe that this may not always remain the case. First, changing sexual practices may increase rates of HPV infection. Second, as women age, they have a lower cell-mediated immune capacity, which increases the probability that newly acquired HPV will persist. Third, in other countries, HPV prevalence has a bimodal age distribution, with a second increase after the age of 65 years. Thus, cervical cancer rates could rise in older women over the coming decades. As, unfortunately, we cannot predict the future, we are left with making policy based on average expected results for large populations. Cost-effectiveness analysis is one tool to assist in this process. Our analyses suggest that, on average, the biennial use of combined HPV and Pap testing remains beneficial until the age of 75 years at reasonable costs, and that lifetime screening still provides more benefits than harms and is within the bounds of acceptable expenditures.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles